We are excited to announce that we are speaking at Bioprocessing Summit Europe 2025 in Barcelona, Spain in March, 2025.
Bioprocessing Summit Europe brings together 750+ upstream, downstream, bioproduction, and analytical professionals from industry and academia to advance the manufacture, quality, and control of next-generation biologics and genetic therapies.
Speaking from the Cell and Gene Therapy Catapult
PANEL: Gene Therapy CMC and Analytics: Improving the Analysis, Control, and Quality of Gene Therapies Towards Commercialization
Title: Cambridge Healthtech Institute’s 5th AnnTitle: Challenges in Downstream Processing for AAV: Addressing Product and Process Related Impurities
Speaker: Katerina Farukshina, Associate Lead Scientist
PANEL: Gene Therapy Manufacturing: Improving Production, Expression and Yield to Reduce Costs
Title: Towards Continuous Upstream Manufacturing: The Future of AAV Production
Speaker: Molly Tregidgo, Senior Bioprocessing Scientist
PANEL: Cell Therapy CMC and Manufacturing: Optimise CMC, Analytical and Manufacturing Strategies to Achieve Commercial Success
Title: Manufacturing Case Study from Cell & Gene Therapy Catapult The Case for Process Characterisation to Drive Quality in Cell Therapy Process Development
Speaker: Jahid Hasan, PhD, Lead, Technical Scientist
Title: Manufacturing Case Study from Cell & Gene Therapy Catapult
Speaker: Matthew Smart, PhD, Lead Scientist